Nigeria’s High-Level Roundtable Ends with Renewed Drive to Boost Local Drug Production and Strengthen Africa’s Health Security

The High Level Roundtable on Local Manufacturing of Medicines in Nigeria has concluded with a renewed commitment from stakeholders to foster collaboration, innovation, and investment aimed at transforming the country’s pharmaceutical landscape.
The event, which brought together key players from government, industry, and development sectors, emphasized the urgent need to expand Nigeria’s capacity for local drug manufacturing as part of broader efforts to achieve health independence and reduce reliance on imported medicines.
Participants agreed that improving pharmaceutical production within Nigeria would not only enhance access to affordable and quality medicines but also contribute significantly to sustainable health security across Africa.
Discussions at the roundtable focused on creating an enabling environment for investment, developing skilled manpower, and strengthening regulatory frameworks that encourage innovation and efficiency within the pharmaceutical sector.
Stakeholders also underscored the importance of public private partnerships and regional cooperation in achieving these goals, noting that the success of Nigeria’s local manufacturing drive could serve as a model for other African nations.
The roundtable ended with a collective resolve to move beyond policy discussions toward practical implementation, with a focus on long term strategies that will ensure a resilient and self reliant health system for the continent.


